Your browser doesn't support javascript.
loading
Embryonal precursors of Wilms tumor.
Coorens, Tim H H; Treger, Taryn D; Al-Saadi, Reem; Moore, Luiza; Tran, Maxine G B; Mitchell, Thomas J; Tugnait, Suzanne; Thevanesan, Christine; Young, Matthew D; Oliver, Thomas R W; Oostveen, Minou; Collord, Grace; Tarpey, Patrick S; Cagan, Alex; Hooks, Yvette; Brougham, Mark; Reynolds, Ben C; Barone, Giuseppe; Anderson, John; Jorgensen, Mette; Burke, G A Amos; Visser, Johannes; Nicholson, James C; Smeulders, Naima; Mushtaq, Imran; Stewart, Grant D; Campbell, Peter J; Wedge, David C; Martincorena, Iñigo; Rampling, Dyanne; Hook, Liz; Warren, Anne Y; Coleman, Nicholas; Chowdhury, Tanzina; Sebire, Neil; Drost, Jarno; Saeb-Parsy, Kourosh; Stratton, Michael R; Straathof, Karin; Pritchard-Jones, Kathy; Behjati, Sam.
Afiliación
  • Coorens THH; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
  • Treger TD; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
  • Al-Saadi R; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Moore L; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Tran MGB; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
  • Mitchell TJ; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
  • Tugnait S; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
  • Thevanesan C; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Young MD; UCL Division of Surgery and Interventional Science, Royal Free Hospital, London NW3 2PS, UK.
  • Oliver TRW; Specialist Centre for Kidney Cancer, Royal Free Hospital, London NW3 2PS, UK.
  • Oostveen M; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
  • Collord G; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Tarpey PS; Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Cagan A; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
  • Hooks Y; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
  • Brougham M; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
  • Reynolds BC; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
  • Barone G; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Anderson J; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.
  • Jorgensen M; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
  • Burke GAA; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
  • Visser J; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
  • Nicholson JC; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Smeulders N; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Mushtaq I; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Stewart GD; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
  • Campbell PJ; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
  • Wedge DC; Department of Haematology and Oncology, Royal Hospital for Sick Children, Edinburgh EH9 1LF, UK.
  • Martincorena I; Department of Paediatric Nephrology, Royal Hospital for Children, Glasgow G51 4TF, UK.
  • Rampling D; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
  • Hook L; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
  • Warren AY; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
  • Coleman N; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
  • Chowdhury T; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Sebire N; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Drost J; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Saeb-Parsy K; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Stratton MR; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Straathof K; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
  • Pritchard-Jones K; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
  • Behjati S; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Science ; 366(6470): 1247-1251, 2019 12 06.
Article en En | MEDLINE | ID: mdl-31806814
ABSTRACT
Adult cancers often arise from premalignant clonal expansions. Whether the same is true of childhood tumors has been unclear. To investigate whether Wilms tumor (nephroblastoma; a childhood kidney cancer) develops from a premalignant background, we examined the phylogenetic relationship between tumors and corresponding normal tissues. In 14 of 23 cases studied (61%), we found premalignant clonal expansions in morphologically normal kidney tissues that preceded tumor development. These clonal expansions were defined by somatic mutations shared between tumor and normal tissues but absent from blood cells. We also found hypermethylation of the H19 locus, a known driver of Wilms tumor development, in 58% of the expansions. Phylogenetic analyses of bilateral tumors indicated that clonal expansions can evolve before the divergence of left and right kidney primordia. These findings reveal embryonal precursors from which unilateral and multifocal cancers develop.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Lesiones Precancerosas / Células Clonales / Tumor de Wilms / Metilación de ADN / Riñón / Neoplasias Renales Límite: Child / Humans Idioma: En Revista: Science Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Lesiones Precancerosas / Células Clonales / Tumor de Wilms / Metilación de ADN / Riñón / Neoplasias Renales Límite: Child / Humans Idioma: En Revista: Science Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido